https://smallcaps.com.au/article/patrys-australian-patent-deoxymab-nanoparticles-deliver-anti-cancer-drugs
Patrys granted Australian patent for Deoxymab platform with nanoparticles to deliver anti-cancer...
Oct 6, 2020 - Therapeutic antibody development company Patrys (ASX: PAB) has been granted an Australian patent covering the use of its novel Deoxymab platform conjugated to...
anti cancerpatrysgrantedaustralianpatent